New Recommendations for the Diagnosis of Pulmonary Embolism

Diagnosis of PE described as challenging process in December issue of AJM




New York - December 4, 2006 – Diagnosis of Pulmonary Embolism (PE) is a challenging process. Because PE is only present in about one-third of those in whom it is suspected, the diagnosis must be confirmed or excluded by further testing. In an article in the December issue of The American Journal of Medicine, researchers describe the diagnostic pathways that can be used to achieve an accurate and safe diagnosis of PE.

Based on the results from the Prospective Investigation of Pulmonary Embolism Diagnosis II (PIOPED II) and other studies, these guidelines include both evidence-based recommendations and opinions based on information available at this time.

Writing in the article, Paul D. Stein, MD, states "[we] recommend stratification of all patients with suspected pulmonary embolism according to an objective probability assessment. A negative D-dimer rapid ELISA with a low or moderate probability clinical assessment can safely exclude pulmonary embolism. If pulmonary embolism is not excluded, CT angiography/CT venography is recommended by most PIOPED II investigators, although CT angiography alone is an option. In patients with discordant findings on clinical assessment and CT imaging, further evaluation depends on clinical judgment. In pregnant women and women of reproductive age, ventilation/perfusion scans are recommended by many PIOPED II investigators as the first imaging test."

In an accompanying commentary, James E. Dalen, MD, MPH, describes how various techniques for the diagnosis of PE have been introduced over the last 40 years, each with advantages and disadvantages in accuracy, risk to the patient and cost. Writing about the article, he states, "These recommendations from the PIOPED investigators will have a major impact on the diagnosis and treatment of pulmonary embolism."

The study is "Diagnostic Pathways in Acute Pulmonary Embolism: Recommendations of The PIOPED II Investigators" by Paul D. Stein, MD, Pamela K. Woodard, MD, John G. Weg, MD, Thomas W. Wakefield, MD, Victor F. Tapson, MD, H. Dirk Sostman, MD, Thomas A. Sos, MD, Deborah A. Quinn, MD, Kenneth V. Leeper, Jr, MD, Russell D. Hull, MBBS, MSc, Charles A. Hales, MD, Alexander Gottschalk, MD, Lawrence R. Goodman, MD, Sarah E. Fowler, PhD, and John D. Buckley, MD, MPH. The commentary is "Prospective Investigation of Pulmonary Embolism Diagnosis (PIOPED I, II, and III) and the Diagnosis of Pulmonary Embolism" by James E. Dalen, MD, MPH. These appear in The American Journal of Medicine, Volume 119, Issue 12 (December 2006), published by Elsevier.

# # #

About The American Journal Of Medicine
The American Journal of Medicine, known as the "Green Journal," is one of the oldest and most prestigious general internal medicine journals published in the United States. AJM, the official journal of The Association of Professors of Medicine, a group comprised of chairs of departments of internal medicine at 125-plus U.S. medical schools, publishes peer-reviewed, original scientific studies that have direct clinical significance. The information contained in this article in The American Journal of Medicine is not a substitute for medical advice or treatment, and the Journal recommends consultation with your physician or healthcare professional. AJM is published by Elsevier.

About Elsevier
Elsevier is a global information analytics business that helps institutions and professionals progress science, advance healthcare and improve performance for the benefit of humanity. Elsevier provides digital solutions and tools in the areas of strategic research management, R&D performance, clinical decision support, and professional education; including ScienceDirect, Scopus, SciVal, ClinicalKey and Sherpath. Elsevier publishes over 2,500 digitized journals, including The Lancet and Cell, more than 35,000 e-book titles and many iconic reference works, including Gray's Anatomy. Elsevier is part of RELX Group, a global provider of information and analytics for professionals and business customers across industries. www.elsevier.com

Media Contact
Pamela Poppalardo
+1 212 633-3944
ajmmedia@elsevier.com

`